share_log

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Ruskin Barbara

SEC announcement ·  Jan 31 16:23
Summary by Moomoo AI
Barbara Ruskin, a reporting person for Virpax Pharmaceuticals, Inc. [VRPX], was involved in a transaction with the company's stock on January 29, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Barbara Ruskin, a reporting person for Virpax Pharmaceuticals, Inc. [VRPX], was involved in a transaction with the company's stock on January 29, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more